Gilead Sciences (NASDAQ:GILD) executives outlined the company’s approach to next-generation HIV medicines, ongoing commercialization efforts in liver disease, and a broad slate of oncology and ...

ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...

Eswatini joined a handful of countries to officially roll out new HIV prevention drug lenacapavir on Wednesday, announcing ...

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

People at risk for contracting HIV from sex can reduce their risk of infection by up to 99% when they take pre-exposure prophylaxis (PrEP), an antiretroviral medication, as directed. However, most ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...

Friday marks the 35th anniversary of World AIDS Day, an international moment to remember, reflect and educate people on the HIV/AIDS epidemic that started over four decades ago. But due to ...

Eswatini introduces lenacapavir, a groundbreaking HIV prevention drug, to combat the burden of the virus. The U.S.-formulated injectable medication is tailored for long-term protection minimizing the ...

A U.S. study by San Diego State University and the RAND Corporation found that intimate partner violence among sexual minority men does not directly reduce PrEP use but can increase stigma and lower ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.